Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease
Why zymogen glycoprotein 2 (GP2), the Crohn’s disease (CD)-specific pancreatic autoantigen, is the major target of humoral autoimmunity in inflammatory bowel diseases (IBD) is uknown. Recent evidence demonstrates that GP2 is also present on the apical surface of microfold (M) intestinal cells. As th...
Main Authors: | Polychronis Pavlidis, Ourania Romanidou, Dirk Roggenbuck, Maria G. Mytilinaiou, Faris Al-Sulttan, Christos Liaskos, Daniel S. Smyk, Andreas L. Koutsoumpas, Eirini I. Rigopoulou, Karsten Conrad, Alastair Forbes, Dimitrios P. Bogdanos |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/640835 |
Similar Items
-
Autoantibodies in Autoimmune Pancreatitis
by: Daniel S. Smyk, et al.
Published: (2012-01-01) -
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease
by: Bogdanos Dimitrios P, et al.
Published: (2012-08-01) -
PBC Triggers in Water Reservoirs, Coal Mining Areas and Waste Disposal Sites: From Newcastle to New York
by: Daniel Smyk, et al.
Published: (2010-01-01) -
The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease
by: Valentina Somma, et al.
Published: (2013-01-01) -
Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges
by: Cristina Rigamonti, et al.
Published: (2011-01-01)